{
    "xml": "<topic id=\"PHP5100\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/solifenacin-succinate\" basename=\"solifenacin-succinate\" title=\"SOLIFENACIN SUCCINATE\">\n<title>SOLIFENACIN SUCCINATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1020\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/solifenacin\">Solifenacin</xref>\n</p>\n<data name=\"vtmid\">407031006</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_567112641\" title=\"Antimuscarinics\">Antimuscarinics</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" namespace=\"/drug-classes/antimuscarinics-systemic\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP70043\" outputclass=\"indicationsAndDose\" rev=\"1.25\" parent=\"/drugs/solifenacin-succinate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Urinary frequency</p>\n<p outputclass=\"therapeuticIndication\">Urinary urgency</p>\n<p outputclass=\"therapeuticIndication\">Urinary incontinence</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg once daily, increased if necessary to 10&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Max. 5&#8239;mg daily with concomitant potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole, ketoconazole, or ritonavir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70154\" outputclass=\"cautions\" rev=\"1.16\" parent=\"/drugs/solifenacin-succinate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Neurogenic bladder disorder</ph>; <ph outputclass=\"caution\">susceptibility to QT-interval prolongation</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69990\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/solifenacin-succinate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-oesophageal reflux</ph>; <ph outputclass=\"sideEffect\">oedema</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dysphonia</ph>; <ph outputclass=\"sideEffect\">hepatic impairment</ph>; <ph outputclass=\"sideEffect\">hyperkalaemia</ph>; <ph outputclass=\"sideEffect\">muscle weakness</ph>; <ph outputclass=\"sideEffect\">reduced appetite</ph>; <ph outputclass=\"sideEffect\">torsade de pointes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70012\" outputclass=\"pregnancy\" parent=\"/drugs/solifenacin-succinate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70170\" outputclass=\"breastFeeding\" parent=\"/drugs/solifenacin-succinate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70062\" outputclass=\"hepaticImpairment\" parent=\"/drugs/solifenacin-succinate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. 5&#8239;mg daily in moderate impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in moderate impairment in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir). </p>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69998\" outputclass=\"renalImpairment\" parent=\"/drugs/solifenacin-succinate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. 5&#8239;mg daily if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59550\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/solifenacin-succinate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>The need for continuing therapy for urinary incontinence should be reviewed every 4&#8211;6 weeks until symptoms stabilise, and then every 6&#8211;12 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP5100-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/solifenacin-succinate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77000\" title=\"Tablet\" namespace=\"/drugs/solifenacin-succinate/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85634\" namespace=\"/drugs/solifenacin-with-tamsulosin\" title=\"SOLIFENACIN WITH TAMSULOSIN\" count=\"1\" rel=\"backlink\">SOLIFENACIN WITH TAMSULOSIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e62183\" href=\"#bnf_d1e62183\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/solifenacin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e62183</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e62205\" href=\"#bnf_d1e62205\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/solifenacin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e62205</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e62227\" href=\"#bnf_d1e62227\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/solifenacin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e62227</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e54428\" href=\"#bnf_d1e54428\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e54428</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1365\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"Ketoconazole\" count=\"1\" rel=\"backlink\">Ketoconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e58741\" href=\"#bnf_d1e58741\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e58741</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_302\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"Itraconazole\" count=\"1\" rel=\"backlink\">Itraconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e80933\" href=\"#bnf_d1e80933\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e80933</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_400\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"Ritonavir\" count=\"1\" rel=\"backlink\">Ritonavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78573\" namespace=\"/treatment-summaries/urinary-frequency-enuresis-and-incontinence\" title=\"Urinary frequency, enuresis and incontinence\" count=\"1\" rel=\"backlink\">Urinary frequency, enuresis and incontinence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1020\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/solifenacin\" title=\"Solifenacin\" count=\"1\" rel=\"link\">Solifenacin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" namespace=\"/drug-classes/antimuscarinics-systemic\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" count=\"1\" rel=\"link\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77000\" namespace=\"/drugs/solifenacin-succinate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP5100",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/solifenacin-succinate",
    "basename": "solifenacin-succinate",
    "title": "SOLIFENACIN SUCCINATE",
    "interactants": [
        {
            "id": "bnf_int_1020",
            "label": "Solifenacin"
        }
    ],
    "vtmid": "407031006",
    "drugClassification": [
        "Antimuscarinics"
    ],
    "inheritsFromClass": [
        "ANTIMUSCARINICS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Urinary frequency",
                        "html": "Urinary frequency"
                    },
                    {
                        "textContent": "Urinary urgency",
                        "html": "Urinary urgency"
                    },
                    {
                        "textContent": "Urinary incontinence",
                        "html": "Urinary incontinence"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg once daily, increased if necessary to 10 mg once daily.",
                        "html": "<p>5&#8239;mg once daily, increased if necessary to 10&#8239;mg once daily.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Max. 5 mg daily with concomitant potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole, ketoconazole, or ritonavir).",
                "html": "<p>Max. 5&#8239;mg daily with concomitant potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole, ketoconazole, or ritonavir).</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Neurogenic bladder disorder",
                "html": "Neurogenic bladder disorder"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to QT-interval prolongation",
                "html": "susceptibility to QT-interval prolongation"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Gastro-oesophageal reflux",
                        "html": "Gastro-oesophageal reflux",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Dysphonia",
                        "html": "Dysphonia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatic impairment",
                        "html": "hepatic impairment",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperkalaemia",
                        "html": "hyperkalaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle weakness",
                        "html": "muscle weakness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "reduced appetite",
                        "html": "reduced appetite",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "torsade de pointes",
                        "html": "torsade de pointes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution&#8212;no information available.",
                "html": "<p>Manufacturer advises caution&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. 5 mg daily in moderate impairment.",
                "html": "<p>Max. 5&#8239;mg daily in moderate impairment.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in moderate impairment in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir).\n\nAvoid in severe impairment.",
                "html": "<p>Avoid in moderate impairment in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir). </p><p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. 5 mg daily if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Max. 5&#8239;mg daily if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR less than 30 mL/minute/1.73 m2 in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir).",
                "html": "<p>Avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> in those already taking potent inhibitors of cytochrome P450 enzyme CYP3A4 (such as itraconazole or ritonavir).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "The need for continuing therapy for urinary incontinence should be reviewed every 4&#8211;6 weeks until symptoms stabilise, and then every 6&#8211;12 months.",
                "html": "<p>The need for continuing therapy for urinary incontinence should be reviewed every 4&#8211;6 weeks until symptoms stabilise, and then every 6&#8211;12 months.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77000",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85634",
                "label": "SOLIFENACIN WITH TAMSULOSIN",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e62183": [
            {
                "id": "bnf_d1e62183",
                "label": "bnf_d1e62183",
                "type": "#bnf_d1e62183"
            }
        ],
        "#bnf_d1e62205": [
            {
                "id": "bnf_d1e62205",
                "label": "bnf_d1e62205",
                "type": "#bnf_d1e62205"
            }
        ],
        "#bnf_d1e62227": [
            {
                "id": "bnf_d1e62227",
                "label": "bnf_d1e62227",
                "type": "#bnf_d1e62227"
            }
        ],
        "#bnf_d1e54428": [
            {
                "id": "bnf_d1e54428",
                "label": "bnf_d1e54428",
                "type": "#bnf_d1e54428"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_1365",
                "label": "Ketoconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_302",
                "label": "Itraconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_400",
                "label": "Ritonavir",
                "type": "interaction"
            }
        ],
        "#bnf_d1e58741": [
            {
                "id": "bnf_d1e58741",
                "label": "bnf_d1e58741",
                "type": "#bnf_d1e58741"
            }
        ],
        "#bnf_d1e80933": [
            {
                "id": "bnf_d1e80933",
                "label": "bnf_d1e80933",
                "type": "#bnf_d1e80933"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78573",
                "label": "Urinary frequency, enuresis and incontinence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1020",
                "label": "Solifenacin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34659",
                "label": "ANTIMUSCARINICS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77000",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}